Table 2.
The evolution of seizure freedom after the initial response in 204 patients with newly diagnosed epilepsy.
| N (%) | χ2 | p-Value | OR | 95% CI | |
|---|---|---|---|---|---|
| All patients (N = 204) | |||||
| Compare the evolution of seizure freedom between 6MSF (N = 131) vs 6MNSF (N = 73) | |||||
| Seizure-free at 6 and 36 months | 94 (71.8) | 46.862 | p < 0.0001 | 9.051 | 4.620–17.730 |
| Not seizure-free at 6 months but seizure-free at 36 months | 16 (21.9) | ||||
| Compare the evolution of seizure freedom between 12MSF (N = 118) vs 12MNSF (N = 86) | |||||
| Seizure-free at 12 and 36 months | 94 (79.7) | 66.720 | p < 0.0001 | 13.811 | 7.007–27.223 |
| Not seizure-free at 12 months but seizure-free at 36 months | 19 (22.1) | ||||
6MSF, patients who were seizure-free over the initial 6 months; 6MNSF, patients who were not seizure-free over the initial 6 months; 12MSF, patients who were seizure-free over the initial 12 months; 12MNSF, patients who were not seizure-free over the initial 12 months; OR, odds ratio; CI, confidence interval.